The primary objective of this Phase 1, open-label, dose-escalation, and exploratory study is to evaluate the safety and tolerability profile (establish the max…

Central Nervous System NeoplasmsGlioblastomaGliosarcoma, Adult+20 more

~Estimated

~$10 – $8,750

Jazz PharmaceuticalsNCT04541082

Observational

Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection

The primary objective of this study is to evaluate the diagnostic performance of the CONVIVO confocal endomicroscope in discriminating between normal and abnor…

GlioblastomaGlial TumorBrain Metastases+3 more

~Estimated

~$10 – $6,250

Dartmouth-Hitchcock Medical CenterNCT05139277